Venetoclax with ibrutinib for treating relapsed mantle cell lymphoma [ID3879]
In development
Reference number: GID-TA10774
Expected publication date: TBC
Please note that following on from information received from the company, the timelines for this appraisal are to be confirmed. An update on the revised timelines will be provided when further information is available.